FR2361899A1 - Nouveaux aminoethers de steroides - Google Patents

Nouveaux aminoethers de steroides

Info

Publication number
FR2361899A1
FR2361899A1 FR7617320A FR7617320A FR2361899A1 FR 2361899 A1 FR2361899 A1 FR 2361899A1 FR 7617320 A FR7617320 A FR 7617320A FR 7617320 A FR7617320 A FR 7617320A FR 2361899 A1 FR2361899 A1 FR 2361899A1
Authority
FR
France
Prior art keywords
aminoethers
new steroid
new
steroid
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7617320A
Other languages
English (en)
Other versions
FR2361899B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Theramex SAM
Original Assignee
Laboratoire Theramex SAM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Theramex SAM filed Critical Laboratoire Theramex SAM
Publication of FR2361899A1 publication Critical patent/FR2361899A1/fr
Application granted granted Critical
Publication of FR2361899B1 publication Critical patent/FR2361899B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0088—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing unsubstituted amino radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Nouveaux composés chimiques utilisables notamment en thérapeutique, caractérisés par la formule générale suivante :
FR7617320A 1975-06-02 1976-06-09 Nouveaux aminoethers de steroides Granted FR2361899A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2518775A GB1565351A (en) 1975-06-02 1975-06-02 Steroid aminoethers

Publications (2)

Publication Number Publication Date
FR2361899A1 true FR2361899A1 (fr) 1978-03-17
FR2361899B1 FR2361899B1 (fr) 1978-12-08

Family

ID=10223653

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7617320A Granted FR2361899A1 (fr) 1975-06-02 1976-06-09 Nouveaux aminoethers de steroides

Country Status (2)

Country Link
FR (1) FR2361899A1 (fr)
GB (1) GB1565351A (fr)

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0113998A2 (fr) * 1982-12-22 1984-07-25 Herpes Pharmaceutical, Inc. Compositions et traitement d'infections virales à Herpes Simplex
WO1994020520A1 (fr) * 1993-03-10 1994-09-15 Magainin Pharmaceuticals Inc. Derives steroidiens, compositions pharmaceutiques contenant ces derives steroidiens et utilisation de ces derniers comme antibiotiques ou desinfectants
WO1995024415A1 (fr) * 1994-03-10 1995-09-14 Magainin Pharmaceuticals Inc. Derives de steroides, compositions pharmaceutiques les contenant et leur utilisations pharmaceutiques
US5763430A (en) * 1995-06-07 1998-06-09 Magainin Pharmaceuticals Inc. Method of treating a viral infection by administering a steroid compound
US5792635A (en) * 1995-06-07 1998-08-11 Magainin Pharmaceuticals, Inc. Method of inhibiting the sodium/proton exchanger NHE3 and method of inhibiting growth by administering squalamine
US5795885A (en) * 1995-06-07 1998-08-18 Magainin Pharmaceuticals Inc. Method of inhibiting profileration of cells by administering an aminosterol compound
US5840740A (en) * 1995-06-07 1998-11-24 Magainin Pharmaceuticals Inc. Aminosterol compounds and a method of treating infection using the aminosterol compounds
US5847172A (en) * 1995-06-07 1998-12-08 Magainin Pharmaceuticals Inc. Certain aminosterol compounds and pharmaceutical compositions including these compounds
US5856535A (en) * 1994-08-18 1999-01-05 Magainin Pharmaceuticals, Inc. Aminosterol ester compounds
US5874597A (en) * 1995-06-07 1999-02-23 Magainin Pharmaceuticals, Inc. Certain aminosterol compounds and pharmaceutical compositions including these compounds
US5994336A (en) * 1995-06-07 1999-11-30 Magainin Pharmaceuticals Inc. Method of inhibiting proliferation of cells by administering an aminosterol compound
US6143738A (en) * 1995-06-07 2000-11-07 Magainin Pharmaceuticals, Inc. Therapeutic uses for an aminosterol compound
US6262283B1 (en) 1996-12-06 2001-07-17 Magainin Pharmaceuticals Inc. Stereoselective synthesis of 24-hydroxylated compounds useful for the preparation of aminosterols, vitamin D analogs, and other compounds
US6596712B2 (en) 1996-04-26 2003-07-22 Genaera Corporation Treatment of carcinomas using squalamine in combination with other anti-cancer agents or modalities
US6933383B2 (en) 2000-04-12 2005-08-23 Genaera Corporation Regioselective and stereoselective oxidation of fused ring systems useful for the preparation of aminosterols
US8987236B2 (en) 2000-07-13 2015-03-24 Ohr Pharmaceutical, Inc. Therapeutic uses for an aminosterol compound

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840936A (en) * 1995-06-07 1998-11-24 Magainin Pharmaceuticals Inc. Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (NHE)
CA2252584C (fr) * 1996-04-26 2008-06-10 Magainin Pharmaceuticals Inc. Traitement des carcinomes par la squalamine en association avec d'autres agents anticancereux

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3000910A (en) * 1961-04-07 1961-09-19 Upjohn Co 17-isonitrose-3-aminoethers of the androstane series
GB937410A (en) * 1961-01-09 1963-09-18 Upjohn Co Improvements in or relating to steroids and the manufacture thereof
US3169132A (en) * 1961-04-07 1965-02-09 Upjohn Co 3-aminoether pregnanes
US3206457A (en) * 1960-11-16 1965-09-14 Searle & Co 3-aminoalkyl ethers of 17-oxygenated androst-5-en-3-ols and 20-oxygenated pregn-5-en-3-ols, and 5alpha, 6-dihydro compounds corresponding
FR2007477A1 (fr) * 1968-04-19 1970-01-09 Gastaud Jean Marie

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3206457A (en) * 1960-11-16 1965-09-14 Searle & Co 3-aminoalkyl ethers of 17-oxygenated androst-5-en-3-ols and 20-oxygenated pregn-5-en-3-ols, and 5alpha, 6-dihydro compounds corresponding
GB937410A (en) * 1961-01-09 1963-09-18 Upjohn Co Improvements in or relating to steroids and the manufacture thereof
US3000910A (en) * 1961-04-07 1961-09-19 Upjohn Co 17-isonitrose-3-aminoethers of the androstane series
US3169132A (en) * 1961-04-07 1965-02-09 Upjohn Co 3-aminoether pregnanes
FR2007477A1 (fr) * 1968-04-19 1970-01-09 Gastaud Jean Marie

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0113998A2 (fr) * 1982-12-22 1984-07-25 Herpes Pharmaceutical, Inc. Compositions et traitement d'infections virales à Herpes Simplex
EP0113998A3 (fr) * 1982-12-22 1984-08-22 Herpes Pharmaceutical, Inc. Compositions et traitement d'infections virales à Herpes Simplex
WO1994020520A1 (fr) * 1993-03-10 1994-09-15 Magainin Pharmaceuticals Inc. Derives steroidiens, compositions pharmaceutiques contenant ces derives steroidiens et utilisation de ces derniers comme antibiotiques ou desinfectants
US5637691A (en) * 1993-03-10 1997-06-10 Magainin Pharmaceuticals, Inc. Steroid derivatives, pharmaceutical compositions containing them, and their use as antibiotics or disinfectants
US5721226A (en) * 1993-03-10 1998-02-24 Magainin Pharmaceuticals Inc. Method for inhibiting angiogenesis using squalamine and squalamine steroid derivatives
US5733899A (en) * 1993-03-10 1998-03-31 Magainin Pharmaceuticals Inc. Method for treating infection using steroid based pharmaceutical compositions
WO1995024415A1 (fr) * 1994-03-10 1995-09-14 Magainin Pharmaceuticals Inc. Derives de steroides, compositions pharmaceutiques les contenant et leur utilisations pharmaceutiques
US5856535A (en) * 1994-08-18 1999-01-05 Magainin Pharmaceuticals, Inc. Aminosterol ester compounds
US5840740A (en) * 1995-06-07 1998-11-24 Magainin Pharmaceuticals Inc. Aminosterol compounds and a method of treating infection using the aminosterol compounds
US6143738A (en) * 1995-06-07 2000-11-07 Magainin Pharmaceuticals, Inc. Therapeutic uses for an aminosterol compound
US5792635A (en) * 1995-06-07 1998-08-11 Magainin Pharmaceuticals, Inc. Method of inhibiting the sodium/proton exchanger NHE3 and method of inhibiting growth by administering squalamine
US5847172A (en) * 1995-06-07 1998-12-08 Magainin Pharmaceuticals Inc. Certain aminosterol compounds and pharmaceutical compositions including these compounds
US5763430A (en) * 1995-06-07 1998-06-09 Magainin Pharmaceuticals Inc. Method of treating a viral infection by administering a steroid compound
US5874597A (en) * 1995-06-07 1999-02-23 Magainin Pharmaceuticals, Inc. Certain aminosterol compounds and pharmaceutical compositions including these compounds
US5994336A (en) * 1995-06-07 1999-11-30 Magainin Pharmaceuticals Inc. Method of inhibiting proliferation of cells by administering an aminosterol compound
US5795885A (en) * 1995-06-07 1998-08-18 Magainin Pharmaceuticals Inc. Method of inhibiting profileration of cells by administering an aminosterol compound
US6596712B2 (en) 1996-04-26 2003-07-22 Genaera Corporation Treatment of carcinomas using squalamine in combination with other anti-cancer agents or modalities
US6262283B1 (en) 1996-12-06 2001-07-17 Magainin Pharmaceuticals Inc. Stereoselective synthesis of 24-hydroxylated compounds useful for the preparation of aminosterols, vitamin D analogs, and other compounds
US6610866B2 (en) 1996-12-06 2003-08-26 Magainin Pharmaceuticals, Inc. Stereoselective synthesis of 24-hydroxylated compounds useful for the preparation of aminosterols, vitamin D analogs, and other compounds
US6933383B2 (en) 2000-04-12 2005-08-23 Genaera Corporation Regioselective and stereoselective oxidation of fused ring systems useful for the preparation of aminosterols
US7728157B2 (en) 2000-04-12 2010-06-01 Ohr Pharmaceutical Inc. Regioselective and stereoselective oxidation of fused ring systems useful for the preparation of aminosterols
US8987236B2 (en) 2000-07-13 2015-03-24 Ohr Pharmaceutical, Inc. Therapeutic uses for an aminosterol compound

Also Published As

Publication number Publication date
FR2361899B1 (fr) 1978-12-08
GB1565351A (en) 1980-04-16

Similar Documents

Publication Publication Date Title
FR2361899A1 (fr) Nouveaux aminoethers de steroides
FR2375250A1 (fr) 3-de-0-methylfortimicines, leur procede de preparation et leur utilisation therapeutique comme antibiotiques
FR2367741A1 (fr) Nouveaux mercaptoacylamino-acides
FR2357556A1 (fr) Procede de transformation de cis-hexahydrodibenzo(b,d) pyran-9-ones en trans-hexahydrodibenzo(b,d) pyran-9-ones
SE7604381L (sv) Fenylalkan karbon syra-derivat
IT1063011B (it) Procedimento per la produzione di idrogeno
FR2354338A1 (fr) Acides n-phosphonomethylene-monoaminoalcane-mono- et polyphosphoniques et acides n-phosphonomethylene-diaminoalcane-polyphosphoniques, et leur preparation
ES451117A1 (es) Un procedimiento para preparar 3-piridil-isoxazolidinas.
ES386565A1 (es) Procedimiento para la obtencion de cianfenil-1,4-dihidropi-rinas.
IT7822832A0 (it) Composizioni contenenti ditranolper il trattamento della psoriasi.
FR2397385A1 (fr) Derives du resorcinol, leur preparation et leurs utilisations therapeutiques
FR2357558A1 (fr) 2,6-methano-2h-1-benzoxocines
ES428005A1 (es) Procedimiento para la preparacion de derivados de 3-4-dihi-dro-2h-naftalenom-(1)-5-oxi-propil-piperazina.
FR2377396A1 (fr) Dithienylalkylamines, leur preparation et leurs utilisations therapeutiques
FR2421179A1 (fr) 3-0-(b-d-glucuronopyrannosyl)-soyasapogenol b, sa preparation et ses utilisations therapeutiques
FR2362125A1 (fr) Spiro(cyclopropane-1,2'-indolin)-3'-ones
FR2372164A1 (fr) Pyridobenzodiazepinones, leur preparation et leurs utilisations therapeutiques
FR2401922A1 (fr) Picolylamides d'acides 4-hydroxy-isophtaliques substitues, leur preparation et leurs utilisations therapeutiques
FR2362851A1 (fr) Composes pharmaceutiques derives de tetrahydropyridine
FR2446841A1 (fr) Procede de preparation de 1a,3b-dihydroxy-d5-steroides
FR2372792A1 (fr) Aminoalcoxybenzenes, leur preparation et leurs utilisations therapeutiques
FR2367767A1 (fr) Nouveaux composes de rifamycine
CH400113A (fr) Procédé de préparation de nouveaux dérivés de l'indanedione-1,3
FR2377417A1 (fr) Nouveaux derives steroides substitues en 11b, ainsi que leur procede de preparation
FR2361405A1 (fr) Nouveaux medicaments du type 7-arylmalonamidocepheme

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse